Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients.

MLA

Brunello, Lucia, et al. “Haplo-Identical Allografting with Post-Transplant Cyclophosphamide in High-Risk Patients.” Annals of Hematology, vol. 97, no. 11, Nov. 2018, pp. 2205–15. EBSCOhost, https://doi.org/10.1007/s00277-018-3433-3.

APA

Brunello, L., Passera, R., Dellacasa, C. M., Giaccone, L., Audisio, E., Ferrero, D., D’ardia, S., Allione, B., Aydin, S., Festuccia, M., Lia, G., Crisà, E., Maffini, E., Butera, S., Busca, A., & Bruno, B. (2018). Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients. Annals of Hematology, 97(11), 2205–2215. https://doi.org/10.1007/s00277-018-3433-3

Chicago

Brunello, Lucia, Roberto Passera, Chiara Maria Dellacasa, Luisa Giaccone, Ernesta Audisio, Dario Ferrero, Stefano D’ardia, et al. 2018. “Haplo-Identical Allografting with Post-Transplant Cyclophosphamide in High-Risk Patients.” Annals of Hematology 97 (11): 2205–15. doi:10.1007/s00277-018-3433-3.